HSIE Results Daily: Sun Pharmaceutical Industries, Bajaj Auto, Jindal Steel...
Sun Pharmaceutical Industries: EBITDA (ex-milestone of USD 55 mn) grew 13% YoY on 13% sales growth (US: -4% QoQ, global specialty: +13% QoQ, India:...
152 Views
APAC Healthcare Weekly (January 25) – InSilico, Daiichi, Shionogi, Alteogen, HK Inno, Sun Pharma
InSilico entered outlicensing deal. Daiichi’s Enhertu got China approval for 6th indication. Shionogi will pick up Pfizer’s stake in ViiV...
529 Views
Pharmaceuticals: IPM: strong 15% growth in Dec-25
Growth was led by CVS, anti-diabetes, CNS, and oncology segments, while growth in anti-infective, gastro, respiratory, and pain grew at par or...
183 Views
Pharma and Healthcare (Q3FY26E Results Preview): Base business momentum to offset gRevlimid drag
The India Pharma and Healthcare sector is expected to see moderate revenue growth as EBITDA margins remain flat. We project sales/EBITDA growth of...
189 Views
APAC Healthcare Weekly (December 7) – Simcere, Kelun Bio, Samsung Biologics, Daiichi Sankyo, Biocon
Simcere stuck license pact with Vigonvita. Kelun Bio inked partnership with Crescent Biopharma. Samsung Biologics is acquiring land for third...
634 Views